Theradiag SA (ALTHE) — Cash Flow-to-Debt Ratio
Theradiag SA (ALTHE) has a Cash Flow-to-Debt Ratio of -0.25x as of June 2025, meaning its operating cash flow of €-3.56 Million could theoretically repay 0% of its total liabilities (€14.09 Million) in one year. See Theradiag SA (ALTHE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Theradiag SA Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Theradiag SA across 14 annual periods. Also explore net asset growth rate of Theradiag SA to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Theradiag SA (2011–2024)
Year-by-year debt coverage analysis for Theradiag SA. For market capitalisation and broader financial context, see Theradiag SA (ALTHE) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.25x | €-2.91 Million | €11.47 Million | ▼ -32.9% |
| 2023 | -0.19x | €-2.48 Million | €13.01 Million | ▲ +51.4% |
| 2022 | -0.39x | €-5.27 Million | €13.40 Million | ▼ -32.6% |
| 2021 | -0.30x | €-3.88 Million | €13.10 Million | ▼ -23.0% |
| 2020 | -0.24x | €-3.32 Million | €13.78 Million | ▲ +30.9% |
| 2019 | -0.35x | €-3.69 Million | €10.59 Million | ▲ +25.6% |
| 2018 | -0.47x | €-4.73 Million | €10.10 Million | ▲ +28.9% |
| 2017 | -0.66x | €-6.79 Million | €10.30 Million | ▲ +24.5% |
| 2016 | -0.87x | €-7.97 Million | €9.13 Million | ▼ -48.9% |
| 2015 | -0.59x | €-4.98 Million | €8.50 Million | ▲ +37.7% |
| 2014 | -0.94x | €-5.18 Million | €5.51 Million | ▼ -57.0% |
| 2013 | -0.60x | €-4.04 Million | €6.75 Million | ▲ +34.8% |
| 2012 | -0.92x | €-2.66 Million | €2.90 Million | ▼ -110.8% |
| 2011 | -0.44x | €-952.02K | €2.19 Million | — |